In contrast, the TP53 mutation-positive group had significantly lower CPS and T cell densities than the wild-type group (Figures 4B–D), and also tended to have lower immune/tumor cell ratios (Supplementary Figure 5D), suggesting the presence of immune-excluded microenvironment characteristics. The gene discussed is TP53; the disease is neoplasm.